161 related articles for article (PubMed ID: 10837964)
1. Survival of human glioma cells treated with various combination of temozolomide and X-rays.
van Rijn J; Heimans JJ; van den Berg J; van der Valk P; Slotman BJ
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):779-84. PubMed ID: 10837964
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumour effects by a trimodal combination of temozolomide, meloxicam and X-rays in cultures of human glioma cells.
van Nifterik KA; Van Den Berg J; Slotman BJ; Van Rijn J
Int J Radiat Biol; 2011 Feb; 87(2):192-201. PubMed ID: 21067299
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid sensitizes human glioma cells for temozolomide and γ-radiation.
Van Nifterik KA; Van den Berg J; Slotman BJ; Lafleur MV; Sminia P; Stalpers LJ
J Neurooncol; 2012 Mar; 107(1):61-7. PubMed ID: 22037799
[TBL] [Abstract][Full Text] [Related]
4. The inhibition of proliferation and migration of glioma spheroids exposed to temozolomide is less than additive if combined with irradiation.
Fehlauer F; Muench M; Richter E; Rades D
Oncol Rep; 2007 Apr; 17(4):941-5. PubMed ID: 17342340
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin augments survival of glioma cells after radiation and temozolomide.
Hassouna I; Sperling S; Kim E; Schulz-Schaeffer W; Rave-Fränk M; Hasselblatt M; Jelkmann W; Giese A; Ehrenreich H
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):927-34. PubMed ID: 19014782
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide.
Kil WJ; Cerna D; Burgan WE; Beam K; Carter D; Steeg PS; Tofilon PJ; Camphausen K
Clin Cancer Res; 2008 Feb; 14(3):931-8. PubMed ID: 18245557
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of temozolomide combined with X-irradiation.
Wedge SR; Porteous JK; Glaser MG; Marcus K; Newlands ES
Anticancer Drugs; 1997 Jan; 8(1):92-7. PubMed ID: 9147618
[TBL] [Abstract][Full Text] [Related]
8. Treatment of poorly differentiated glioma using a combination of monoclonal antibodies to extracellular connexin-43 fragment, temozolomide, and radiotherapy.
Yusubalieva GM; Baklaushev VP; Gurina OI; Zorkina YA; Gubskii IL; Kobyakov GL; Golanov AV; Goryainov SA; Gorlachev GE; Konovalov AN; Potapov AA; Chekhonin VP
Bull Exp Biol Med; 2014 Aug; 157(4):510-5. PubMed ID: 25110095
[TBL] [Abstract][Full Text] [Related]
9. Optimizing radiotherapy of brain tumours by a combination of temozolomide & lonidamine.
Prabhakara S; Kalia VK
Indian J Med Res; 2008 Aug; 128(2):140-8. PubMed ID: 19001677
[TBL] [Abstract][Full Text] [Related]
10. Silver nanoparticles enhance the sensitivity of temozolomide on human glioma cells.
Liang P; Shi H; Zhu W; Gui Q; Xu Y; Meng J; Guo X; Gong Z; Chen H
Oncotarget; 2017 Jan; 8(5):7533-7539. PubMed ID: 27893419
[TBL] [Abstract][Full Text] [Related]
11. Cediranib enhances control of wild type EGFR and EGFRvIII-expressing gliomas through potentiating temozolomide, but not through radiosensitization: implications for the clinic.
Wachsberger PR; Lawrence RY; Liu Y; Xia X; Andersen B; Dicker AP
J Neurooncol; 2011 Nov; 105(2):181-90. PubMed ID: 21516367
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of short-term cultures derived from human malignant glioma to the anti-cancer drug temozolomide.
Sankar A; Thomas DG; Darling JL
Anticancer Drugs; 1999 Feb; 10(2):179-85. PubMed ID: 10211548
[TBL] [Abstract][Full Text] [Related]
13. O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.
Hermisson M; Klumpp A; Wick W; Wischhusen J; Nagel G; Roos W; Kaina B; Weller M
J Neurochem; 2006 Feb; 96(3):766-76. PubMed ID: 16405512
[TBL] [Abstract][Full Text] [Related]
14. Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe.
Pérès EA; Gérault AN; Valable S; Roussel S; Toutain J; Divoux D; Guillamo JS; Sanson M; Bernaudin M; Petit E
Oncotarget; 2015 Feb; 6(4):2101-19. PubMed ID: 25544764
[TBL] [Abstract][Full Text] [Related]
15. Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide.
Sheehan J; Cifarelli CP; Dassoulas K; Olson C; Rainey J; Han S
J Neurosurg; 2010 Aug; 113(2):234-9. PubMed ID: 20001586
[TBL] [Abstract][Full Text] [Related]
16. Temozolomide: too early for definitive conclusions.
Brown P; Buckner J
J Clin Oncol; 2003 Oct; 21(19):3710. PubMed ID: 14512412
[No Abstract] [Full Text] [Related]
17. Concomitant treatment with temozolomide enhances apoptotic cell death in glioma cells induced by photodynamic therapy with talaporfin sodium.
Miki Y; Akimoto J; Omata H; Moritake K; Hiranuma M; Hironaka C; Fujiwara Y; Beppu M
Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):556-64. PubMed ID: 25262961
[TBL] [Abstract][Full Text] [Related]
18. IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway.
Li K; Ouyang L; He M; Luo M; Cai W; Tu Y; Pi R; Liu A
Oncotarget; 2017 Apr; 8(17):28865-28879. PubMed ID: 28427200
[TBL] [Abstract][Full Text] [Related]
19. Combined radiotherapy and temozolomide in patients with recurrent high grade glioma.
Schönekaes K; Mücke R; Panke J; Rama B; Wagner W
Tumori; 2002; 88(1):28-31. PubMed ID: 12004846
[TBL] [Abstract][Full Text] [Related]
20. Expression of ABC-1 transporter is elevated in human glioma cells under irradiation and temozolomide treatment.
Trog D; Moenkemann H; Haertel N; Schüller H; Golubnitschaja O
Amino Acids; 2005 Mar; 28(2):213-9. PubMed ID: 15723240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
